Torii Pharmaceutical Co. Ltd. | Ownership
Companies that own Torii Pharmaceutical Co. Ltd.
Effissimo Capital Management Pte Ltd.
2,428,100
8.43%
-7,100
0.7%
11/20/2017
Brandes Investment Partners LP
1,442,600
5.01%
1,442,600
0.23%
06/30/2017
Dimensional Fund Advisors LP
387,300
1.35%
26,100
0%
04/30/2018
The Vanguard Group, Inc.
276,216
0.96%
200
0%
07/31/2018
Norges Bank Investment Management
267,799
0.93%
116,299
0%
12/31/2017
Nomura Asset Management Co., Ltd.
184,098
0.64%
-25,601
0%
07/31/2018
Daiwa Asset Management Co. Ltd.
88,400
0.31%
-13,000
0%
07/31/2018
Nikko Asset Management Co., Ltd.
80,599
0.28%
-57,101
0%
08/20/2018
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
39,201
0.14%
-3,799
0%
07/31/2018
TIAA-CREF Investment Management LLC
30,100
0.11%
0
0%
03/31/2018
| Address |
Torii Nihonbashi Building
Tokyo Tokyo 103
Japan
|
|
Employees
|
- |
| Website |
http://www.torii.co.jp |
| Updated |
07/08/2019 |
| Torii Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products are mainly used in the areas of renal diseases and hemodialysis, human immunodeficiency virus (HIV), skin diseases and allergies, active bacteria formulation (laxative), tocolysis, eclampsia and others. The company was founded by Tokubei Torii in 1872 and is headquartered in Tokyo, Japan. |
